Skip to main content
Top

01-04-2019 | Computed Tomography | Case report

Acute arteritis after G-CSF administration

Authors: Yasuyuki Kinjo, Tomoko Kurita, Taeko Ueda, Seiji Kagami, Yusuke Matsuura, Kiyoshi Yoshino

Published in: International Cancer Conference Journal | Issue 2/2019

Login to get access

Abstract

Granulocyte colony-stimulating factor (G-CSF) is commonly used in clinical practice to accelerate neutropenia recovery after chemotherapy. G-CSF is a myeloid growth factor produced by monocytes, macrophages, fibroblasts and endothelial cells. Generally, aortitis and arteritis are not a known side effect of G-CSF and is thought to be extremely rare. Here, we present a case of a 77-year-old woman who underwent adjuvant chemotherapy (combined paclitaxel and carboplatin) for ovarian cancer, and then developed acute arteritis after receiving G-CSF. She developed grade 4 neutropenia on day 7 of the third chemotherapy cycle and received six G-CSF administrations. Two days after G-CSF administration, she came down with a high-grade fever that persisted for 2 weeks. Laboratory tests revealed a white blood cell count of 8700 UI, neutrophilic sequestration of 61.5%, and C-reactive protein of 8.43 mg/dl at the highest point of her fever. Considering that we were initially treating neutropenia, we diagnosed a bacterial infection, and she was treated with a course of antibiotics. However, her blood and urinalysis cultures were negative, and antibiotics were ineffective; thus, we performed a computed tomography scan to search for the cause of her persistent fever. The computed tomography scan showed remarkable thickness of the bilateral common carotid artery and the left subclavian artery consistent with arteritis. With cessation of the antibiotics course, she was followed closely without therapy, and her condition resolved in a few days. We conclude that G-CSF induced arteritis due to our exclusion of other probable etiologies.
Literature
1.
go back to reference D’Souza A, Jaiyesimi I, Trainor L et al (2008) Granulocyte colony-stimulating factor administration: adverse events. Transfus Med Rev 22(4):280–290CrossRefPubMed D’Souza A, Jaiyesimi I, Trainor L et al (2008) Granulocyte colony-stimulating factor administration: adverse events. Transfus Med Rev 22(4):280–290CrossRefPubMed
2.
go back to reference McMullin MF, Finch MB (1995) Felty’s syndrome treated with rhG-CSF associated with flare of arthritis and skin rash. Clin Rheumatol 14(2):204–208CrossRefPubMed McMullin MF, Finch MB (1995) Felty’s syndrome treated with rhG-CSF associated with flare of arthritis and skin rash. Clin Rheumatol 14(2):204–208CrossRefPubMed
3.
go back to reference Hayat SQ, Hearth-Holmes M, Wolf RE (1995) Flare of arthritis with successful treatment of Felty’s syndrome with granulocyte colony stimulating factor (GCSF). Clin Rheumatol 14(2):211–212CrossRefPubMed Hayat SQ, Hearth-Holmes M, Wolf RE (1995) Flare of arthritis with successful treatment of Felty’s syndrome with granulocyte colony stimulating factor (GCSF). Clin Rheumatol 14(2):211–212CrossRefPubMed
4.
go back to reference Iking-Konert C, Ostendorf B, Foede M et al (2004) Granulocyte colony-stimulating factor induces disease flare in patients with antineutrophil cytoplasmic antibody-associated vasculitis. J Rheumatol 31(8):1655–1658PubMed Iking-Konert C, Ostendorf B, Foede M et al (2004) Granulocyte colony-stimulating factor induces disease flare in patients with antineutrophil cytoplasmic antibody-associated vasculitis. J Rheumatol 31(8):1655–1658PubMed
5.
go back to reference Farhey YD, Herman JH (1995) Vasculitis complicating granulocyte colony stimulating factor treatment of leukopenia and infection in Felty’s syndrome. J Rheumatol 22(6):1179–1182PubMed Farhey YD, Herman JH (1995) Vasculitis complicating granulocyte colony stimulating factor treatment of leukopenia and infection in Felty’s syndrome. J Rheumatol 22(6):1179–1182PubMed
6.
go back to reference Vidarsson B, Geirsson AJ, Onundarson PT (1995) Reactivation of rheumatoid arthritis and development of leukocytoclastic vasculitis in a patient receiving granulocyte colony-stimulating factor for Felty’s syndrome. Am J Med 98(6):589–591CrossRefPubMed Vidarsson B, Geirsson AJ, Onundarson PT (1995) Reactivation of rheumatoid arthritis and development of leukocytoclastic vasculitis in a patient receiving granulocyte colony-stimulating factor for Felty’s syndrome. Am J Med 98(6):589–591CrossRefPubMed
8.
go back to reference Rojo-Leyva F, Ratliff NB, Cosgrove DM et al (2000) Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum 43(4):901–907CrossRefPubMed Rojo-Leyva F, Ratliff NB, Cosgrove DM et al (2000) Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum 43(4):901–907CrossRefPubMed
9.
go back to reference Darie C, Boutalba S, Fichter P et al (2004) Aortitis after G-CSF injections. Rev Med Interne 25(3):225–229CrossRefPubMed Darie C, Boutalba S, Fichter P et al (2004) Aortitis after G-CSF injections. Rev Med Interne 25(3):225–229CrossRefPubMed
10.
go back to reference Adiga GU, Elkadi D, Malik SK et al (2009) Abdominal aortitis after use of granulocyte colony-stimulating factor. Clin Drug Investig 29(12):821–825CrossRefPubMed Adiga GU, Elkadi D, Malik SK et al (2009) Abdominal aortitis after use of granulocyte colony-stimulating factor. Clin Drug Investig 29(12):821–825CrossRefPubMed
11.
go back to reference Miller EB, Grosu R, Landau Z (2016) Isolated abdominal aortitis following administration of granulocyte colony stimulating factor (G-CSF). Clin Rheumatol 35(6):1655–1657CrossRefPubMed Miller EB, Grosu R, Landau Z (2016) Isolated abdominal aortitis following administration of granulocyte colony stimulating factor (G-CSF). Clin Rheumatol 35(6):1655–1657CrossRefPubMed
12.
go back to reference Sloand EM, Kim S, Maciejewski JP et al (2000) Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood 95(7):2269–2274PubMed Sloand EM, Kim S, Maciejewski JP et al (2000) Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood 95(7):2269–2274PubMed
Metadata
Title
Acute arteritis after G-CSF administration
Authors
Yasuyuki Kinjo
Tomoko Kurita
Taeko Ueda
Seiji Kagami
Yusuke Matsuura
Kiyoshi Yoshino
Publication date
01-04-2019
Publisher
Springer Singapore
Published in
International Cancer Conference Journal / Issue 2/2019
Electronic ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-018-00357-z
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine